The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.

por Fosså, S. D., Waehre, H., Paus, E.
Publicado em 1992

Late recurrences of germ cell malignancies: a population-based experience over three decades

por Oldenburg, J, Alfsen, G C, Wæhre, H, Fosså, S D
Publicado em 2006

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.

por Berner, A., Nesland, J. M., Waehre, H., Silde, J., Fosså, S. D.
Publicado em 1993

DNA ploidy in primary testicular cancer.

por Fosså, S. D., Nesland, J. M., Pettersen, E. O., Amellem, O., Waehre, H., Heimdal, K.
Publicado em 1991

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection

por Jacobsen, K D, Ous, S, Wæhre, H, Trasti, H, Stenwig, A E, Lien, H H, Aass, N, Fosså, S D
Publicado em 1999

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

por Mu, L J, Kyte, J A, Kvalheim, G, Aamdal, S, Dueland, S, Hauser, M, Hammerstad, H, Waehre, H, Raabe, N, Gaudernack, G
Publicado em 2005

Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.

por Fosså, S. D., Berner, A. A., Jacobsen, A. B., Waehre, H., Kvarstein, B., Urnes, T., Ogreid, P., Johansen, T. E., Silde, J., Nesland, J. M.
Publicado em 1993